ArticleObstetrics and gynecology international2026
Limited Role of
Article in Obstetrics and gynecology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the role of Design: Multicenter prospective cohort study. Setting: Three hospitals and one Centre for Sexual Health (CSH) in the Netherlands. Population: Women ≥ 18 years with clinically diagnosed PID and/or TOA between 2021 and 2023. Methods: Clinical examination, C-reactive protein (CRP) levels, and vaginal swabs were evaluated at baseline and follow-up. Participants completed a self-reported symptom diary. Antibiotic therapy was prescribed in accordance with Dutch national hospital and CSH guidelines. Main Outcome Measures: The primary outcome, clinical cure at Week 4, was defined as the absence of fever and vomiting, CRP < 10 mg/L, and ≥ 70% reduction in symptom score. Microbiological cure was the secondary outcome. Results: Among 100 women with PID and/or TOA, monoinfections with Conclusions: Most PID and/or TOA cases lacked an identifiable STI etiology. Nonetheless, the majority showed clinical and microbiological cure, supporting current empiric treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.